- Home
- EWTX vs STBA Comparison
EWTX vs STBA Comparison
Compare EWTX & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- STBA
- Stock Information
- Founded
- EWTX 2017
- STBA 1902
- Country
- EWTX United States
- STBA United States
- Employees
- EWTX N/A
- STBA N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- STBA Major Banks
- Sector
- EWTX Health Care
- STBA Finance
- Exchange
- EWTX Nasdaq
- STBA Nasdaq
- Market Cap
- EWTX 1.5B
- STBA 1.5B
- IPO Year
- EWTX 2021
- STBA N/A
- Fundamental
- Price
- EWTX $15.57
- STBA $39.58
- Analyst Decision
- EWTX Buy
- STBA Hold
- Analyst Count
- EWTX 9
- STBA 3
- Target Price
- EWTX $39.89
- STBA $42.00
- AVG Volume (30 Days)
- EWTX 782.1K
- STBA 127.0K
- Earning Date
- EWTX 08-07-2025
- STBA 10-16-2025
- Dividend Yield
- EWTX N/A
- STBA 3.44%
- EPS Growth
- EWTX N/A
- STBA N/A
- EPS
- EWTX N/A
- STBA 3.40
- Revenue
- EWTX N/A
- STBA $388,489,000.00
- Revenue This Year
- EWTX N/A
- STBA $7.12
- Revenue Next Year
- EWTX N/A
- STBA $5.09
- P/E Ratio
- EWTX N/A
- STBA $11.63
- Revenue Growth
- EWTX N/A
- STBA 1.05
- 52 Week Low
- EWTX $10.60
- STBA $30.84
- 52 Week High
- EWTX $38.12
- STBA $45.46
- Technical
- Relative Strength Index (RSI)
- EWTX 64.68
- STBA 59.88
- Support Level
- EWTX $13.93
- STBA $38.60
- Resistance Level
- EWTX $15.12
- STBA $40.08
- Average True Range (ATR)
- EWTX 0.71
- STBA 0.86
- MACD
- EWTX 0.10
- STBA 0.15
- Stochastic Oscillator
- EWTX 90.29
- STBA 74.56
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.